Doble, Adam
Foxymed,
France
2024 Rank: 227243
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1772 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 227243 | 264772 |
| Total Cites | 158 | 158 |
| H-index | 7 | 7 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 49 | 49 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 50 | 50 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 61 | 61 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 145 | 145 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.09 |
| Self-Citation Percentage |
0.00%
|
|
Doble, Adam
Foxymed,
France
2023 Rank: 276980
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2273 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 276980 | 315861 |
| Total Cites | 145 | 151 |
| H-index | 6 | 6 |
| Hm-index | 2 | 3 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 40 | 40 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 44 | 44 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 53 | 53 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 131 | 136 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.11 |
| Self-Citation Percentage |
3.97%
|
|
Doble, Adam
Foxymed,
France
2022 Rank: 253192
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2048 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 253192 | 275848 |
| Total Cites | 142 | 144 |
| H-index | 6 | 7 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 42 | 42 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 48 | 48 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 54 | 54 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 136 | 137 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.05 |
| Self-Citation Percentage |
1.39%
|
|
Doble, Adam
Medical Research,
France
2021 Rank: 186675
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1425 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 186675 | 211235 |
| Total Cites | 222 | 230 |
| H-index | 8 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 72 | 74 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 82 | 86 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 91 | 97 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 209 | 211 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.09 |
| Self-Citation Percentage |
3.48%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.